Cite
Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide.
MLA
Topkan, Erkan, et al. “Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide.” International Journal of Inflammation, June 2020, pp. 1–8. EBSCOhost, https://doi.org/10.1155/2020/6947382.
APA
Topkan, E., Besen, A. A., Mertsoylu, H., Kucuk, A., Pehlivan, B., & Selek, U. (2020). Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide. International Journal of Inflammation, 1–8. https://doi.org/10.1155/2020/6947382
Chicago
Topkan, Erkan, Ali A. Besen, Huseyin Mertsoylu, Ahmet Kucuk, Berrin Pehlivan, and Ugur Selek. 2020. “Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide.” International Journal of Inflammation, June, 1–8. doi:10.1155/2020/6947382.